We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A new UK proposal would allow the country’s healthcare administration to consider “burden of illness” as a measurable component when assessing new medical products for government reimbursement. Read More
The FDA is proposing to establish five categories of Class III devices, delineated by risks, benefits and available controls — a move that could help to streamline classification of high-risk devices and promote consistent expectations about the process. Read More
The Medical Device Manufacturers Association is urging members of Congress and other stakeholders to address provisions in anti-patent troll legislation that the group says could harm small medtech innovators. Read More
The FDA may withdraw a humanitarian device exemption if it subsequently approves a PMA or clears a 510(k) for the humanitarian-use device or a comparable device with the same indication, a draft Q&A guidance on HDEs explains. Read More
The European Commission’s Scientific Committee on Emerging Newly Identified Health Risks is recommending a step-by-step approach to the introduction of new or technically modified metal-on-metal joint implants, citing continued concerns about the higher risks and poorer durability vis-à-vis alternative materials such as polyethylene. Read More